Previous 10 | Next 10 |
home / stock / ttoo / ttoo articles
LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathog...
PHILADELPHIA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating T2 Biosystems, Inc. (NASDAQ:TTOO) ("T2") on b...
Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group ...
Gainers RVL Pharmaceuticals plc (NASDAQ: RVLP) shares rose 181.8% to $0.2201 in pre-market trading. Novo Integrated Sciences, Inc. (NASDAQ: NVOS) ...
CR Group LP, 10% Owner at T2 Biosystems (NASDAQ:TTOO), reported a large insider sell on September 27, according to a new SEC filing. What Happened...
CR Group LP, 10% Owner at T2 Biosystems (NASDAQ:TTOO), reported a large insider sell on September 26, according to a new SEC filing. What Happened...
The Nasdaq 100 closed higher by around 0.5% on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it ...
T2 Biosystems, Inc. (NASDAQ: TTOO) shares are trading lower Monday. The stock has fallen more than 50% over the last five days. What To Know:...
CR Group LP, 10% Owner at T2 Biosystems (NASDAQ:TTOO), reported a large insider sell on September 21, according to a new SEC filing. What Happened...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in Hong Kong and Macau. Under the terms ...
2024-06-18 09:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it received written notice from the Nasdaq Stock Market LLC (ȁ...